3,0
12 mag 2018
Dipendente attuale, più di un anno
Houston, TX
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Opportunity to learn gene and cell therapy technology. Great benefits.
Svantaggi
Too many mistakes, from top to bottom. Failing results pass, with justification. Too much emphasis on risk assessment which doesn't mean much.